Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Dutasteride may help shrink prostate cancer tumors.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

ERG increases SOX9, promoting prostate cancer growth and invasion.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Markers help differentiate between apocrine and eccrine sweat glands to identify sweat gland tumors.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

A 69-year-old man with sinus infection and fainting spells was diagnosed with a rare kidney disease, treated with steroids and a specific drug, which improved his condition.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Medications improve quality of life for men with lower urinary tract symptoms.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

New treatments for male hypogonadism are effective and should be personalized.